Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
EMEA(Europe, Middle East and Africa)Influenza Drugs and Vaccines Market Report 2017
Publication Date Jun 2017
Product Type Report
Pages 111
Single User License help $ 4000.00
Corporate User License help $ 8000.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

In this report, the EMEA Influenza Drugs and Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Influenza Drugs and Vaccines for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Influenza Drugs and Vaccines market competition by top manufacturers/players, with Influenza Drugs and Vaccines sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline
Sanofi Pasteur, Inc.
CSL Limited
Astrazeneca
Protein Sciences Corporation
Serum Institute Of India Pvt. Ltd.
Emergent Biosolutions
Emergent Biosolutions
BioCryst Pharmaceuticals.Inc.
Alvogen
ABPI

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Zanamivir
Oseltamivir Phosphate
Peramivir
Trivalent
Quadrivalent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Influenza Drugs and Vaccines for each application, including
Hospitals
Research Laboratories
Pharmacies
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Influenza Drugs and Vaccines Market Report 2017
1 Influenza Drugs and Vaccines Overview
1.1 Product Overview and Scope of Influenza Drugs and Vaccines
1.2 Classification of Influenza Drugs and Vaccines
1.2.1 EMEA Influenza Drugs and Vaccines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Influenza Drugs and Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Zanamivir
1.2.4 Oseltamivir Phosphate
1.2.5 Peramivir
1.2.6 Trivalent
1.2.7 Quadrivalent
1.3 EMEA Influenza Drugs and Vaccines Market by Application/End Users
1.3.1 EMEA Influenza Drugs and Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Pharmacies
1.3.5 Others
1.4 EMEA Influenza Drugs and Vaccines Market by Region
1.4.1 EMEA Influenza Drugs and Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Influenza Drugs and Vaccines (2012-2022)
1.5.1 EMEA Influenza Drugs and Vaccines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Influenza Drugs and Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Influenza Drugs and Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Influenza Drugs and Vaccines Market Competition by Players/Manufacturers
2.1.1 EMEA Influenza Drugs and Vaccines Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Influenza Drugs and Vaccines Revenue and Share by Players (2012-2017)
2.1.3 EMEA Influenza Drugs and Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Influenza Drugs and Vaccines (Volume and Value) by Type/Product Category
2.2.1 EMEA Influenza Drugs and Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Influenza Drugs and Vaccines Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Influenza Drugs and Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Influenza Drugs and Vaccines (Volume) by Application
2.4 EMEA Influenza Drugs and Vaccines (Volume and Value) by Region
2.4.1 EMEA Influenza Drugs and Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Influenza Drugs and Vaccines Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Influenza Drugs and Vaccines Sales Price by Region (2012-2017)

3 Europe Influenza Drugs and Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Influenza Drugs and Vaccines Sales and Value (2012-2017)
3.1.1 Europe Influenza Drugs and Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Influenza Drugs and Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Influenza Drugs and Vaccines Sales and Market Share by Type
3.3 Europe Influenza Drugs and Vaccines Sales and Market Share by Application
3.4 Europe Influenza Drugs and Vaccines Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Influenza Drugs and Vaccines Sales Volume by Countries (2012-2017)
3.4.2 Europe Influenza Drugs and Vaccines Revenue by Countries (2012-2017)
3.4.3 Germany Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
3.4.4 France Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
3.4.5 UK Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
3.4.6 Russia Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
3.4.7 Italy Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
3.4.8 Benelux Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Influenza Drugs and Vaccines (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Influenza Drugs and Vaccines Sales and Value (2012-2017)
4.1.1 Middle East Influenza Drugs and Vaccines Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Influenza Drugs and Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Influenza Drugs and Vaccines Sales and Market Share by Type
4.3 Middle East Influenza Drugs and Vaccines Sales and Market Share by Application
4.4 Middle East Influenza Drugs and Vaccines Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Influenza Drugs and Vaccines Sales Volume by Countries (2012-2017)
4.4.2 Middle East Influenza Drugs and Vaccines Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
4.4.4 Israel Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
4.4.5 UAE Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
4.4.6 Iran Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)

5 Africa Influenza Drugs and Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Influenza Drugs and Vaccines Sales and Value (2012-2017)
5.1.1 Africa Influenza Drugs and Vaccines Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Influenza Drugs and Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Influenza Drugs and Vaccines Sales and Market Share by Type
5.3 Africa Influenza Drugs and Vaccines Sales and Market Share by Application
5.4 Africa Influenza Drugs and Vaccines Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Influenza Drugs and Vaccines Sales Volume by Countries (2012-2017)
5.4.2 Africa Influenza Drugs and Vaccines Revenue by Countries (2012-2017)
5.4.3 South Africa Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
5.4.5 Egypt Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)
5.4.6 Algeria Influenza Drugs and Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Influenza Drugs and Vaccines Manufacturers/Players Profiles and Sales Data
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi Pasteur, Inc.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 CSL Limited
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 CSL Limited Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Astrazeneca
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Astrazeneca Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Protein Sciences Corporation
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Serum Institute Of India Pvt. Ltd.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Emergent Biosolutions
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Emergent Biosolutions
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 BioCryst Pharmaceuticals.Inc.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Alvogen
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Influenza Drugs and Vaccines Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 ABPI

7 Influenza Drugs and Vaccines Manufacturing Cost Analysis
7.1 Influenza Drugs and Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Drugs and Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Influenza Drugs and Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Drugs and Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Influenza Drugs and Vaccines Market Forecast (2017-2022)
11.1 EMEA Influenza Drugs and Vaccines Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Influenza Drugs and Vaccines Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Influenza Drugs and Vaccines Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Influenza Drugs and Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Influenza Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Influenza Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Influenza Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Influenza Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Influenza Drugs and Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Influenza Drugs and Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Figures
List of Tables and Figures

Figure Product Picture of Influenza Drugs and Vaccines
Figure EMEA Influenza Drugs and Vaccines Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Influenza Drugs and Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Zanamivir Product Picture
Figure Oseltamivir Phosphate Product Picture
Figure Peramivir Product Picture
Figure Trivalent Product Picture
Figure Quadrivalent Product Picture
Figure EMEA Influenza Drugs and Vaccines Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Influenza Drugs and Vaccines by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Research Laboratories Examples
Table Key Downstream Customer in Research Laboratories
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Influenza Drugs and Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Influenza Drugs and Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Influenza Drugs and Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Influenza Drugs and Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Influenza Drugs and Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Influenza Drugs and Vaccines Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales Share by Players (2012-2017)
Figure 2016 Influenza Drugs and Vaccines Sales Share by Players
Figure 2017 Influenza Drugs and Vaccines Sales Share by Players
Figure EMEA Influenza Drugs and Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Influenza Drugs and Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Influenza Drugs and Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Influenza Drugs and Vaccines Revenue Share by Players
Table 2017 EMEA Influenza Drugs and Vaccines Revenue Share by Players
Table EMEA Influenza Drugs and Vaccines Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Influenza Drugs and Vaccines by Type (2012-2017)
Figure EMEA Influenza Drugs and Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Influenza Drugs and Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Influenza Drugs and Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Drugs and Vaccines by Type in 2016
Table EMEA Influenza Drugs and Vaccines Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Influenza Drugs and Vaccines by Application (2012-2017)
Figure EMEA Influenza Drugs and Vaccines Sales Market Share by Application in 2016
Table EMEA Influenza Drugs and Vaccines Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Influenza Drugs and Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Influenza Drugs and Vaccines by Region (2012-2017)
Figure EMEA Influenza Drugs and Vaccines Sales Market Share in 2016
Table EMEA Influenza Drugs and Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Influenza Drugs and Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Influenza Drugs and Vaccines by Region (2012-2017)
Figure EMEA Influenza Drugs and Vaccines Revenue Market Share Regions in 2016
Table EMEA Influenza Drugs and Vaccines Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Influenza Drugs and Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Influenza Drugs and Vaccines Sales (K MT) by Type (2012-2017)
Table Europe Influenza Drugs and Vaccines Market Share by Type (2012-2017)
Figure Europe Influenza Drugs and Vaccines Market Share by Type in 2016
Table Europe Influenza Drugs and Vaccines Sales (K MT) by Application (2012-2017)
Table Europe Influenza Drugs and Vaccines Market Share by Application (2012-2017)
Figure Europe Influenza Drugs and Vaccines Market Share by Application in 2016
Table Europe Influenza Drugs and Vaccines Sales (K MT) by Countries (2012-2017)
Table Europe Influenza Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs and Vaccines Sales Market Share by Countries in 2016
Table Europe Influenza Drugs and Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Influenza Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs and Vaccines Revenue Market Share by Countries in 2016
Figure Germany Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure France Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure UK Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Influenza Drugs and Vaccines Sales (K MT) by Type (2012-2017)
Table Middle East Influenza Drugs and Vaccines Market Share by Type (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Market Share by Type (2012-2017)
Table Middle East Influenza Drugs and Vaccines Sales (K MT) by Applications (2012-2017)
Table Middle East Influenza Drugs and Vaccines Market Share by Applications (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Sales Market Share by Application in 2016
Table Middle East Influenza Drugs and Vaccines Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Influenza Drugs and Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Influenza Drugs and Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Influenza Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Drugs and Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Influenza Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Influenza Drugs and Vaccines Sales (K MT) by Type (2012-2017)
Table Africa Influenza Drugs and Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Influenza Drugs and Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Influenza Drugs and Vaccines Sales Market Share by Type in 2016
Table Africa Influenza Drugs and Vaccines Sales (K MT) by Application (2012-2017)
Table Africa Influenza Drugs and Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Influenza Drugs and Vaccines Sales Market Share by Application (2012-2017)
Table Africa Influenza Drugs and Vaccines Sales Volume (K MT) by Countries (2012-2017)
Table Africa Influenza Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs and Vaccines Sales Market Share by Countries in 2016
Table Africa Influenza Drugs and Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Influenza Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs and Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Table GlaxoSmithKline Influenza Drugs and Vaccines Basic Information List
Table GlaxoSmithKline Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Basic Information List
Table Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table CSL Limited Influenza Drugs and Vaccines Basic Information List
Table CSL Limited Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Limited Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure CSL Limited Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure CSL Limited Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Astrazeneca Influenza Drugs and Vaccines Basic Information List
Table Astrazeneca Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Astrazeneca Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Astrazeneca Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Astrazeneca Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Protein Sciences Corporation Influenza Drugs and Vaccines Basic Information List
Table Protein Sciences Corporation Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Protein Sciences Corporation Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Protein Sciences Corporation Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Protein Sciences Corporation Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Basic Information List
Table Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Emergent Biosolutions Influenza Drugs and Vaccines Basic Information List
Table Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Emergent Biosolutions Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Emergent Biosolutions Influenza Drugs and Vaccines Basic Information List
Table Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Emergent Biosolutions Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Emergent Biosolutions Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Basic Information List
Table BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Alvogen Influenza Drugs and Vaccines Basic Information List
Table Alvogen Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Alvogen Influenza Drugs and Vaccines Sales (K MT) and Growth Rate (2012-2017)
Figure Alvogen Influenza Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Alvogen Influenza Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table ABPI Influenza Drugs and Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Drugs and Vaccines
Figure Manufacturing Process Analysis of Influenza Drugs and Vaccines
Figure Influenza Drugs and Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Influenza Drugs and Vaccines Major Manufacturers in 2016
Table Major Buyers of Influenza Drugs and Vaccines
Table Distributors/Traders List
Figure EMEA Influenza Drugs and Vaccines Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Drugs and Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Drugs and Vaccines Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Influenza Drugs and Vaccines Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Influenza Drugs and Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Influenza Drugs and Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Influenza Drugs and Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Influenza Drugs and Vaccines Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Influenza Drugs and Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Influenza Drugs and Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Influenza Drugs and Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Drugs and Vaccines Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Influenza Drugs and Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Drugs and Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Influenza Drugs and Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Drugs and Vaccines Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Influenza Drugs and Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Drugs and Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Influenza Drugs and Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Influenza Drugs and Vaccines Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Influenza Drugs and Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Influenza Drugs and Vaccines Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Influenza Drugs and Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  QYResearch

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z